Eric Brusca Ph.D.

Partner, Chair of Biotech & Life Sciences

For clients producing biotech advancements in biologics, vaccines, and next-generation therapeutics, Eric M. Brusca, Ph.D. secures patent protection internationally through strategic prosecution and related proceedings. As Chair of Marshall Gerstein’s Biotech & Life Sciences Practice, he counsels companies, research institutions, and investors on building and managing high-value intellectual property portfolios. Clients rely on his experience handling a wide variety of complex technologies, as well as his ability to provide clear, insightful assessments of patentable products and processes, all grounded in his graduate training and research in microbiology, biochemistry, and molecular biology.

Eric’s practice extends beyond traditional patent procurement. He advises clients on global portfolio strategy, freedom-to-operate, and lifecycle management, helping align intellectual property strategies with business, clinical, and investment objectives. He is particularly valued for his ability to navigate evolving patentability issues, including §101 eligibility considerations for emerging life sciences innovations. A teacher as well, Eric serves as Chair of the firm’s Professional Development Committee, where he leads attorney training and mentoring initiatives. He communicates effectively with clients and colleagues alike and consistently delivers practical, business-oriented guidance while successfully representing clients’ interests.

• The John Marshall Law School (J.D.)
• Loyola University Chicago (Ph.D.)
  • Chemistry
• University of Illinois, Urbana-Champaign (M.S.)
  • Microbiology
• University of Illinois, Urbana-Champaign (B.S.)
  • Microbiology